Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin Lymphoma: Real-World Data in Chinese PopulationZixun Yan,Dehui Zou,Yuhua Li,Xiaojian Zhu,Dongmei Ji,Wenbin Qian,Ying Lu,Chunyan Ji,Keshu Zhou,Hongmei Jing,Hua Yang,Lanfang Li,Fei Li,Kailin Xu,Ting Niu,Depei Wu,Yu Hu,Weili ZhaoBlood(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要